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Introduction
We recently proposed a set of provisional, evidence-based,
clinical criteria for the classification of children and adults
patients affected by monogenic periodic fevers. These cri-
teria, built and validated in a cohort of 1215 patients with
periodic fever enrolled in the Eurofever Registry from
November 2009 to February 2013, displayed a high sensi-
tivity and specificity.
Objectives
To prospectively validate the provisional Eurofever clini-
cal classification criteria in an independent set of patients
with periodic fevers enrolled in the registry after March
2013
Methods
The provisional Eurofever classification criteria (best
accuracy cut-off) were applied to patients with periodic
fevers enrolled in the registry after March 2013. The fol-
lowing disease were analyzed: FMF, MKD, TRAPS,
CAPS, PFAPA and undefined periodic fevers. Patients
were divided in three subgroups: i) group A: inherited
periodic fevers with genetic confirmation, ii) group B:
inherited periodic fevers with non-confirmatory genetic
test, iii) group C: negative controls. Statistical analysis
compared the sensitivity and specificity of best accuracy
cut-off in patients belonging to group A and C.
Results
A total of 245 patients were evaluated. Among them 80
were classified in group A (35 FMF, 28 MKD, 9 TRAPS,
8 CAPS), 94 in group B (56 FMF, 6 MKD, 9 TRAPS,
23 CAPS) and 71 in group C (59 PFAPA and 12 undefined
periodic fever). The classification criteria tested on patients
belonging to Group A and C displayed an overall good
sensitivity and specificity (respectively 85% and 92% for
FMF, 92% and 89% for MKD, 100% and 96% for CAPS
and 100% and 93% for TRAPS). (see table 1). The perfor-
mance of the classification criteria in patients with non-
confirmatory genetic test are reported in Table 1 below.
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FMF MKD CAPS TRAPS FMF MKD CAPS TRAPS
Genetically confirmed (Group A) 85% 92% 100% 100% 92% 89% 96% 93%
Not genetically confirmed (Group B) 58% 67% 45% 25% 94% 79% 100% 82%
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Conclusion
Perspective validation of Eurofever classification criteria
showed their good accuracy in patients with confirmatory
genetic test. Despite a lower sensitivity, the criteria dis-
played an high specificity in the classification of patients
with non-confirmatory molecular test. In order to evaluate
the actual accuracy of the classification criteria in this lat-
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